Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 941

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 5
Chunk 941
---
,341)

    Net loss 
     (9,144,797) 
     (6,592,723)

    Weighted average common shares outstanding - basic 
     2,870,120  
     1,866,275 
  
    Net loss per shares - basic 
    $(3.19) 
    $(3.53)
  
    Weighted average common shares outstanding - diluted 
     2,887,268  
    $1,866,275 
  
    Net loss per shares - diluted 
    $(3.30) 
    $(3.53)

The
accompanying notes are an integral part of these consolidated financial statements.

F-3

Shuttle
Pharmaceuticals Holdings, Inc.

Consolidated
Statements of Changes in Stockholders’ Equity

For
the Years Ended December 31, 2024 and 2023

    Shares  
    Amount  
    Capital  
    Deficit  
    Equity 

    Additional  
       
    Total 

    Common Stock  
    Paid-In  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Equity 
  
    Balance at December 31, 2022 
     1,700,414  
    $17  
    $26,518,433  
    $(18,840,581) 
    $   7,677,869 
  
    Warrants issued for financing costs, net of issuance fees of $8,727 
     —  
     —  
     90,816  
     —  
     90,816 
  
    Common stock issued for conversion of accrued interest and principal 
     297,625  
     3  
     2,697,846  
     —  
     2,697,849 
  
    Common stock issued for restricted stock units 
     10,650  
     —  
     —  
     —  
     — 
  
    Stock-based compensation 
     —  
     —  
     181,960  
     —  
     181,960 
  
    Net loss 
     —  
     —  
     —  
     (6,592,723) 
     (6,